The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Research Funding - GlaxoSmithKline; GlaxoSmithKline (Inst)
Post-hoc analyses of overall survival (OS) and progression-free survival (PFS) in the TRIO-013/LOGiC trial of lapatinib (L) in combination with capecitabine plus oxaliplatin (CapeOx).
 
Yung-Jue Bang
Honoraria - GlaxoSmithKline
Consulting or Advisory Role - GlaxoSmithKline
Research Funding - GlaxoSmithKline (Inst)
 
Shukui Qin
No Relationships to Disclose
 
Hyun-Choel Chung
No Relationships to Disclose
 
Jian-Ming Xu
No Relationships to Disclose
 
Joon Oh Park
Research Funding - GlaxoSmithKline; Sanofi
 
Krzysztof Jeziorski
No Relationships to Disclose
 
Yaroslav Shparyk
No Relationships to Disclose
 
Paulo M. Hoff
Research Funding - GlaxoSmithKline (Inst)
 
Alberto F. Sobrero
Honoraria - Amgen; Bayer; Merck; Roche; Sanofi
Consulting or Advisory Role - Amgen; Merck; Roche
Speakers' Bureau - Amgen; Sanofi
 
Pamela Salman
Consulting or Advisory Role - Bristol-Myers Squibb; Novartis
 
Jin Li
Honoraria - Pfizer; Roche
Research Funding - Jiangsu Hengrui Medicine; Merck
 
Svetlana Protsenko
No Relationships to Disclose
 
Marc E. Buyse
Employment - IDDI
Stock and Other Ownership Interests - IDDI
 
Karen Afenjar
Travel, Accommodations, Expenses - GlaxoSmithKline; Roche
 
Vincent Houe
No Relationships to Disclose
 
Agathe Garcia
No Relationships to Disclose
 
Yingjie Huang
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Alison Armour
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Dennis J. Slamon
No Relationships to Disclose
 
J. Randolph Hecht
Research Funding - GlaxoSmithKline (Inst)